NLM Digital Collections

Search

Search Constraints

Start Over You searched for: Genre Technical Report Remove constraint Genre: Technical Report Copyright Public domain Remove constraint Copyright: Public domain

Search Results

1191. States’ backlogs of standard surveys of nursing homes grew substantially during the COVID-19 pandemic

1192. High-expenditure Medicare drugs often qualified for Orphan Drug Act incentives designed to encourage the development of treatments for rare diseases

1193. CMS could improve the data it uses to monitor antipsychotic drugs in nursing homes

1194. SAMHSA is missing opportunities to better monitor access to medication-assisted treatment through the buprenorphine waiver program

1195. Concerns persist about opioid overdoses and Medicare beneficiaries’ access to treatment and overdose-reversal drugs

1196. Characteristics of separated children in ORR’s care: June 27, 2018–November 15, 2020

1197. Drug safety: FDA should take additional steps to improve its foreign inspection program : report to congressional requesters

1198. Some Medicare Advantage companies leveraged chart reviews and health risk assessments to disproportionately drive payments

1199. Hospitals reported that the COVID-19 pandemic has significantly strained health care delivery

1200. Analysis of 2017 premium changes and insurer participation in the Affordable Care Act's health insurance marketplaces